Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Quick Answer Neither peptide is objectively "better." Available studies indicate BPC-157 is a systemic "jack-of-all-trades" healer that accelerates repair via angiogenesis (blood vessel creation) and the nitric oxide pathway, with a profound affinity for the gastrointestinal tract and tendons
Other growth factors such as bone morphogenetic proteins (BMPs) have received FDA approval for specific indications and may represent more appropriate therapeutic choices for conditions where approved therapies are available and indicated
They are especially beneficial for individuals with B12 deficiency, which can lead to symptoms like fatigue, weakness, and anemia
Christensen, J
Additional information Competing interests Boston University has intellectual property related to the work described in this manuscript
US$ 21.20
US$ 20.27
US$ 28.48